The global legalisation of marijuana for both medical and recreational use has rapidly evolved over the past decade. Attitudes and legal frameworks continue to change with ongoing research which helps raise important questions about how legalising marijuana may impact public health, patient care, pharmaceuticals, and the healthcare industry at large.
Cardiac electrophysiology has made significant advancements in recent years, with new cardiac treatments and devices addressing complex heart conditions, including cardiac arrhythmia.
Vicarious trauma is a type of trauma that healthcare professionals may experience as a result of their exposure to the trauma and suffering of their patients.
Between January 2020 and March 2023, over 170 new oncology treatments were approved by the FDA. New approvals for the first quarter of 2023 include treatments for non-small cell lung cancer (NSCLC), breast cancer, prostate cancer, and leukaemia.
Last year, researchers made significant progress in the development of new psoriasis treatments, with the FDA approving four new treatments.
